¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Full gene sequence"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oligohydroamnios sequence
    ¾ç¼ö°ú¼ÒÁõ¿¬¼â
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • packaging sequence
    ²Ù¸®±â¼ø¼­
  • rapid-sequence induction
    ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
  • rapid-sequence intubation
    ºü¸¥¿¬¼Ó±â°ü»ð°ü
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
  • respiratory sequence
    È£Èí¼ø¼­
  • radio frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • sequence
    1. ¼ø¼­ 2. ¼­¿­ 3. ¿¬¼â
  • signal sequence
    ½ÅÈ£¼ø¼­
  • ultra fast sequence
    Ãʰí¼Ó¿¬¼â
  • autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
  • additive gene
    »ó°¡À¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • flow sensitive gradient echo sequence
    È帧¹Î°¨±â¿ï±â¸Þ¾Æ¸®¿¬¼â
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • imaging sequence
    ¿µ»ó¿¬¼â
  • insertion sequence
    »ðÀÔ¼­¿­
  • intervening sequence
    (¢¡intron) ÀÎÆ®·Ð
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • rapid-sequence induction
    ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
  • rapid-sequence intubation
    ºü¸¥¿¬¼Ó±â°ü»ð°ü
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • oligohydroamnios sequence
    ¾ç¼ö°ú¼Ò¼ø¼­
  • packaging sequence
    ²Ù¸®±â¼ø¼­
  • partial saturation spin echo sequence
    ºÎºÐÆ÷È­½ºÇɸ޾Ƹ®¿¬¼â
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • full-thickness filtering surgery
    ÀüüÃþ¿©°ú¼ö¼ú
  • full-thickness macular hole
    ÀüüÃþȲ¹Ý¿ø°ø
  • full-thickness tear
    ÀüüÃþ¿­°ø
  • imaging of STIR sequence
    STIR ¿¬¼â ¿µ»ó
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • infant at full term =t. f.
    ¸¸±â»ê¾Æ(ػѢ ß§ä®).
  • insertion sequence, IS
    »ðÀÔ¼­¿­, »ðÀÔ¿ä¼Ò
  • porters sequence
    Æ÷ÅÍ¿¬¼â(¡­ææáð), Æ÷Å͹迭¼ø(¡­ÛÕÖªâ÷)
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
  • reaction sequence
    ¹ÝÀÀ¼ø¼­.
  • C-fos gene
    ¾¾-Æ÷½ºÀ¯ÀüÀÚ(ë¶îîí­)
  • C-jun gene
    ¾¾-ÁØ À¯ÀüÀÚ(ë¶îîí­)
  • DNA mediated gene transfer
    DNA ¸Å°³¼ºÀ¯ÀüÀÚÀüÀÌ
  • DP gene
    DPÀ¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • breech disruption sequence
  • delta sequence
    µ¨Å¸ ¼­¿­
  • driven equilibrium Fourier transform sequence
    ÃßÁø ÆòÇü Fourier º¯È¯ ¿¬¼â
  • echo train sequence
    ¿¡ÄÚ ¿­ ¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • flow compensated pulse sequence
    À¯µ¿ º¸»ó ÆÞ½º ¿¬¼â
  • flow sensitive gradient echo sequence
    À¯µ¿ ¹Î°¨ °æ»ç ¿¡ÄÚ ¿¬¼â
  • gradient echo (GRE) pulse sequence
    °æ»ç ¿¡ÄÚ ÆÞ½º ¿¬¼â
  • gradient echo sequence
    °æ»ç ¿¡ÄÚ ¿¬¼â
  • imaging of STIR sequence
    STIR ¿¬¼â ¿µ»ó
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • insertion sequence, IS
    »ðÀÔ¼­¿­, »ðÀÔ¿ä¼Ò
  • intervening sequence (intron)
    ÀÎÆ®·Ð, Àü±¸À¯ÀüÀÚ Çã¼­¿­
  • inversion recovery pulse sequence
    ¿ªÀü ȸº¹ ÆÞ½º ¿¬¼â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • regulatory sequence
    Á¶Àý ¼­¿­(ðàï½ßíÖª)
  • repeated DNA sequence
    ¹Ýº¹(ÚãÜÖ)DNA ¼­¿­(ßíÖª)
  • sequence
    ¼­¿­(ßíÖª)
  • sequence complexity
    ¼­¿­º¹À⼺(ßíÖªÜÜíÚàõ)
  • sequence gap
    ¼­¿­(ßíÖª)Æ´
  • sequence isomer
    ¼­¿­À̼ºÃ¼(ßíÖªì¶àõô÷)
  • sequence polymer
    ¼­¿­ÁßÇÕü(ßíÖªñìùêô÷)
  • sequence rules
    ¼­¿­À²(ßíÖªëÏ)
  • sequence feedback inhibition
    ¼­¿­(ßíÖª) µÇ¸ÔÀÓÀúÇØ(îÁúª)
  • Shine-Dalgarno sequence
    »þÀÎ-´Þ°¡³ë ¼­¿­(ßíÖª)
  • short interspersed repeated sequence
    ´Ü»êÀç ¹Ýº¹¼­¿­ (ӭߤî¤ÚãÜÖßíÖª)
  • signal sequence
    ½ÅÈ£¼­¿­(ãáûÜßíÖª)
  • simple sequence DNA
    ´Ü¼ø¼­¿­(Ó¤âíßíÖª) DNA
  • target sequence
    Ç¥Àû¼­¿­ (øöîÜßíÖª)
  • waterfall sequence
    ÆøÆ÷ ¼­¿­ (øîøÖßíÖª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • imaging of STIR sequence
    STIR¿¬¼â¿µ»ó
  • imaging sequence
    ¿µ»ó¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • multislice FLASH sequence
    ´ÙÀýÆíFLASH¿¬¼â
  • partial saturation spin echo sequence
    ºÎºÐÆ÷È­½ºÇÉ¿¡ÄÚ¿¬¼â
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • sequence
    ¿¬¼â, ¹è¿­¼ø(¼­)
  • sequence
    ¿¬¼â, ¿¬¼Ó
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • ultra fast sequence
    Ãʰí¼Ó¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MSP Minute Sequence Pyelogram
RSP Rapid Sequence IVP
aa seq amino acid sequence
ABS abdominal surgery; acute brain syndrome; Adaptive Behavior Scale; admitting blood sugar; adult bovin...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FL Full length
FWHM Full width at half maximum
FTMH Full-thickness macular holes
FTSG full thickness skin graft
FWHM full width half maximum
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀü ȸº¹ ÆÞ½º ¿¬¼â
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
  • allelic gene
    ´ë¸³ À¯ÀüÀÚ
  • C-jun gene
    ¾¾-ÁØ À¯ÀüÀÚ
  • cancer suppressor gene
    ¾Ï ¾ïÁ¦ À¯ÀüÀÚ
  • contiguous gene syndrome
    Á¢Ã˼º À¯ÀüÀÚ ÁõÈıº
  • control gene
    Á¦¾î À¯ÀüÀÚ
  • dominant gene
    ¿ì¼º À¯ÀüÀÚ
  • duplicate gene
    Áߺ¹ À¯Àü ÀÎÀÚ
  • exaggeration gene
    °­Á¶ À¯ÀüÀÚ
  • fcc gene
    FCC À¯ÀüÀÚ
  • histocompatibility gene
    Á¶Á÷ ÀûÇÕ À¯ÀüÀÚ, Á¶Á÷ ÀûÇÕ¼º À¯ÀüÀÚ
    ÀÌ½ÄµÈ Á¶Á÷À» ÀÚ±â Á¶Á÷ ¶Ç´Â ¿ÜºÎ Á¶Á÷À¸·Î ÀνÄÇÏ´Â À¯ÀüÀÚ.
  • Is gene
    Is À¯ÀüÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
base sequence analysis <molecular biology> A method, sometimes automated, for determining the base sequence.
(09 Oct 1997)
canonical sequence Of a series of related DNA, RNA or protein sequences, the sequence that reflects the most common choice of base or amino acid at each position. Areas of particularly good agreement often represent conserved functional domains. The generation of consensus sequences has been subjected to intensive mathematical analysis.
(18 Nov 1997)
carbohydrate sequence The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids.
(12 Dec 1998)
palindromic sequence <molecular biology> Nucleic acid sequence that is identical to its complementary strand when each is read in the correct direction (e.g. TGGCCA). Palindromic sequences are often the recognition sites for restriction enzymes. Degenerate palindromes with internal mismatching can lead to loops or hairpins being formed (as in tRNA).
(18 Nov 1997)
recognition sequence A nucleotide sequence --typically composed of 4, 6, or 8nucleotides -- that is recognised by a restriction endonuclease. Type II enzymes cut (and theircorresponding modification enzymes methylate) within or very near the recognition sequence.
(09 Oct 1997)
regulatory sequence <molecular biology> DNA sequence to which regulatory molecules such as promotors or enhancers bind, thereby altering the expression of the adjacent gene.
(18 Nov 1997)
centromeric sequence <molecular biology> Special sequences of DNA nucleotides found on chromosomes which provide a site for the attachment of spindle fibres during nuclear division (mitosis or meiosis).
(09 Oct 1997)
chi sequence <molecular biology> A specific sequence of nucleotides on a site on the genome of the bacteria Escherichia coli which strongly encourages recombination and crossing over to occur at that site.
(05 Jan 1998)
PEST sequence Amino acid motif that is thought to target cytoplasmic proteins for rapid proteolytic degradation.
(18 Nov 1997)
molecular sequence data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as genbank, european molecular biology laboratory (embl), national biomedical research foundation (nbrf), or other sequence repositories.
(12 Dec 1998)
coding sequence The portion of DNA that codes for transcription of messenger RNA.
See: exon.
(05 Mar 2000)
monotonic sequence A sequence in which each value in a set is greater than the preceding value.
(05 Mar 2000)
complementary sequence <molecular biology> Nucleicacid base sequences that can form a double-stranded structure bymatching base pairs, the complementary sequence to G-T-A-C is C-A-T-G.
(09 Oct 1997)
consensus sequence Of a series of related DNA, RNA or protein sequences, the sequence that reflects the most common choice of base or amino acid at each position. Areas of particularly good agreement often represent conserved functional domains. The generation of consensus sequences has been subjected to intensive mathematical analysis.
(18 Nov 1997)
conserved sequence <molecular biology> A base sequence in a DNA molecule (or an amino acid sequence in a protein) that has remained essentially unchanged throughout evolution.
(10 Nov 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gene therapy
    À¯ÀüÀÚ ¿ä¹ý(°á¼ÕµÈ À¯ÀüÀÚ¸¦ º¸ÃæÇÏ¿© À¯Àüº´À» °íÄ¡´Â ¿ä¹ý)
  • nif gene
    (»ýÈ­)Áú¼Ò °íÁ¤¿¡ °ü¿©ÇÏ´Â À¯ÀüÀÚ
  • recessive gene
    ¿­¼º À¯ÀüÀÚ
  • regulator(regulatory) gene
    Á¶Àý(Á¦¾î)À¯ÀüÀÚ
  • restorer gene
    ȸº¹ À¯ÀüÀÚ
  • be full of
    ..À¸·Î °¡µæÂ÷´Ù
  • full
    °¡µæÂù,ÃæºÐÇÑ,ÀüºÎ,ÃæºÐ
  • chuck-full
    =CHOCK-FULL
  • full
    °¡µæ Âù;ÃæºÐÇÑ;ÃÖ´ëÇÑÀÇ;(õÀ»)ÃàÀ¶ÇÏ´Ù;ÃæºÐÇÑ;¿ÏÀüÈ÷;²À;ÇÊ¿äÀÌ»óÀ¸·Î;ÀüºÎ;¿ÏÀü;ÇÑâ;³«³«È÷ ÁÖ¸§ Àâ´Ù;º¸¸§´ÞÀÌ µÇ´Ù
  • full
    (»¡°í »î¾Æ¼­) õÀÇ ¿ÃÀ» ¹è°Ô ÇÏ´Ù;´õ¿î ¹°¿¡ ³Ö¾ú´Ù ²¨³»´Ù
  • full age
    ¼º³â
  • full base
    ¸¸·ç
  • full binding
    ÃÑÇÇ Á¦º»
  • full blast
    Àü°¡µ¿(À¸·Î)
  • full blood
    ¼øÁ¾ÀÇ »ç¶÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á